HomeBAFNAPH • NSE
add
Bafna Pharmaceuticals Ltd
Previous close
₹81.23
Day range
₹78.21 - ₹81.50
Year range
₹73.25 - ₹113.00
Market cap
1.92B INR
Avg Volume
5.86K
P/E ratio
698.82
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
(INR) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 332.86M | -20.65% |
Operating expense | 84.22M | -18.08% |
Net income | -7.24M | -111.39% |
Net profit margin | -2.17 | -114.33% |
Earnings per share | — | — |
EBITDA | 10.16M | -84.17% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(INR) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 13.96M | -82.13% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 808.39M | — |
Shares outstanding | 23.34M | — |
Price to book | 2.36 | — |
Return on assets | — | — |
Return on capital | -0.55% | — |
Cash Flow
Net change in cash
(INR) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -7.24M | -111.39% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1981
Website
Employees
363